Phase 2 Trial of Nivolumab, an Anti-Pd-1 Monoclonal Antibody, as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer
International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.12.295
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Elsevier BV